Latest Intellectual Property News

Etherstack plc has delivered a record half year performance in H1 2025, driven by a landmark multi-year contract with AT&T and surging recurring revenues. The wireless communications specialist is poised for sustained growth across its core markets.

Etherstack plc has reported a remarkable turnaround in its half-year results, with revenue nearly doubling and EBITDA surging by over 1500%, signaling strong momentum in mission critical communications.

Felix Group Holdings Limited announces a strategic acquisition of Nexvia Pty Ltd to boost vendor monetisation and expand its SaaS platform capabilities, supported by a $16 million capital raise. The deal is expected to increase Felix’s pro-forma ARR by 38%, positioning the company for accelerated growth.

Argent BioPharma has signed a binding term sheet to acquire key assets from AusCann Group Holdings, significantly expanding its clinical pipeline, intellectual property, and European manufacturing and distribution capabilities ahead of a planned US stock exchange listing.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

AdNeo Limited has issued a prospectus to facilitate secondary trading of shares issued without prior disclosure, following its acquisition of Learnt Global and a $5.65 million capital raise. The company also offers multiple options to investors, directors, brokers, and consultants as part of its growth strategy.

EcoGraf Limited has been granted its first Australian patent for its innovative HFfree® purification technology, reinforcing its position in the battery anode materials market. This milestone follows a recent breakthrough that cut purification costs by 25%, boosting the commercial potential of its purification facilities.

Microequities Asset Management Group Limited reported a 19.3% rise in net profit for FY25, driven by strong fund performance and a surge in performance fees, while declaring a fully franked final dividend of 2.0 cents per share.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

EcoGraf Limited reveals a major breakthrough in its HFfree® graphite purification technology, cutting operating costs by 25% and projecting a US$282 million NPV for its initial 25,000 tonnes per annum facility. This positions the company as a competitive, eco-friendly supplier amid rising global demand and geopolitical shifts in battery materials.

I Synergy Group Limited has formalised a A$300,000 contract with Treasure Global Inc. to supply AI-focused GPUs and specialised software, marking a strategic step in its technology evolution.

Hazer Group has filed patents for a breakthrough graphite purification process that could unlock access to the lucrative battery materials market amid tightening global supply. This innovation positions Hazer to meet surging demand for high-purity graphite essential for lithium-ion batteries.